Compliant peptide programs, ready to launch
Peptide therapies are used in wellness and longevity care to support targeted physiological functions. They are well suited for structured, provider-led telehealth programs. WIZLO takes a prescription-based approach to enable brands to offer peptide programs through a licensed Provider Network.
Clinical framework
All peptide programs operate under designated provider-approved protocols, including: Prescribing decisions are made solely by licensed clinicians.
- Standardized patient screening and eligibility
- Defined treatment and monitoring guidelines
- Ongoing medical oversight
Education included
Each supported peptide includes pre-built, provider-reviewed education:
- Consumer-facing materials to support informed use and adherence
- Business-facing guidance to enable compliant positioning and launch
What’s supported
Most clinically established peptide therapies used in wellness and longevity care.
Why brands use this model
WIZLO enables peptides programs to launch quickly while remaining compliant:
- Faster launches with lower regulatory risk
- Consistent care through standardized protocols
- Built-in education reduces operational and compliance burden
- Clear separation between brand, provider, and pharmacy
Launch peptides with confidence
WIZLO provides the infrastructure, provider network, and compliance framework required to operate peptides programs safely and at scale.